The present study was conducted in order to study the immunohistochemical expression of p16INK4A in a large number of archival sections of different degrees of precancerous lesions and cervical cancer using tissue microarray (TMA) technology and to find the optimal evaluation method of p16INK4A expression for practical diagnostic purposes. The gene discussed is CDKN2A; the disease is cervical carcinoma.